Migrifen may be available in the countries listed below.
Dihydroergotamine mesilate (a derivative of Dihydroergotamine) is reported as an ingredient of Migrifen in the following countries:
International Drug Name Search
Hydrocyclin may be available in the countries listed below.
Hydrocortisone is reported as an ingredient of Hydrocyclin in the following countries:
Oxytetracycline is reported as an ingredient of Hydrocyclin in the following countries:
International Drug Name Search
Simvastatina Acost may be available in the countries listed below.
Simvastatin is reported as an ingredient of Simvastatina Acost in the following countries:
International Drug Name Search
Cystagon is a brand name of cysteamine, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Cystagon available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cystagon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Cystagon.
The following drugs and medications are in some way related to, or used in the treatment of Primary Hyperaldosteronism. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Xylocaina Jalea may be available in the countries listed below.
Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Xylocaina Jalea in the following countries:
International Drug Name Search
Kastair may be available in the countries listed below.
Montelukast sodium salt (a derivative of Montelukast) is reported as an ingredient of Kastair in the following countries:
International Drug Name Search
